Trivium Point Advisory’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.42M | Sell |
8,936
-218
| -2% | -$83.5K | 0.37% | 71 |
|
2025
Q1 | $3.16M | Sell |
9,154
-165
| -2% | -$57K | 0.39% | 76 |
|
2024
Q4 | $2.8M | Buy |
9,319
+320
| +4% | +$96K | 0.35% | 82 |
|
2024
Q3 | $3.14M | Sell |
8,999
-3,221
| -26% | -$1.13M | 0.44% | 73 |
|
2024
Q2 | $3.93M | Buy |
12,220
+75
| +0.6% | +$24.1K | 0.58% | 47 |
|
2024
Q1 | $4.05M | Buy |
12,145
+115
| +1% | +$38.4K | 0.87% | 33 |
|
2023
Q4 | $3.26M | Buy |
12,030
+359
| +3% | +$97.2K | 0.79% | 41 |
|
2023
Q3 | $2.85M | Sell |
11,671
-4,615
| -28% | -$1.13M | 0.78% | 34 |
|
2023
Q2 | $4.94M | Sell |
16,286
-344
| -2% | -$104K | 1.34% | 15 |
|
2023
Q1 | $4.38M | Buy |
16,630
+145
| +0.9% | +$38.2K | 1.18% | 20 |
|
2022
Q4 | $4.2M | Buy |
16,485
+150
| +0.9% | +$38.2K | 1.22% | 20 |
|
2022
Q3 | $3.29M | Buy |
16,335
+125
| +0.8% | +$25.2K | 1.02% | 28 |
|
2022
Q2 | $2.83M | Buy |
16,210
+369
| +2% | +$64.4K | 0.85% | 35 |
|
2022
Q1 | $3.97M | Buy |
15,841
+178
| +1% | +$44.6K | 0.88% | 29 |
|
2021
Q4 | $4.02M | Sell |
15,663
-164
| -1% | -$42.1K | 0.84% | 35 |
|
2021
Q3 | $3.84M | Sell |
15,827
-5
| -0% | -$1.21K | 0.91% | 26 |
|
2021
Q2 | $3.27M | Buy |
15,832
+765
| +5% | +$158K | 0.82% | 32 |
|
2021
Q1 | $2.84M | Buy |
15,067
+625
| +4% | +$118K | 0.77% | 30 |
|
2020
Q4 | $2.51M | Buy |
14,442
+725
| +5% | +$126K | 0.72% | 35 |
|
2020
Q3 | $1.71M | Buy |
13,717
+4,705
| +52% | +$587K | 0.6% | 57 |
|
2020
Q2 | $894K | Buy |
+9,012
| New | +$894K | 0.35% | 96 |
|